Intelligent Bio Solutions Ratios (2020-2024) | INBS

Ratios Sep2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024
Profitability
Gross Margin 68.42%7.23%11.19%29.18%26.08%21.67%
EBT Margin -1,942.94%-9,164.97%-200.33%-698.25%-174.60%-597.03%-1,389.76%-609.84%-322.03%-264.42%-362.44%
EBIT Margin -1,196.16%-9,158.69%-201.67%-697.57%-174.89%-597.45%-1,431.63%-609.86%-317.35%-260.63%-358.55%
EBITDA Margin -2,034.18%-9,929.13%-205.49%-696.80%-180.72%-18.36%-1,406.78%-588.31%-307.81%-248.83%-380.04%
Operating Margin -1,196.16%-9,158.69%-201.67%-697.57%-174.89%-597.45%-1,431.63%-609.86%-317.35%-260.63%-358.55%
Net Margin -1,942.94%-9,164.97%-200.33%-698.25%-174.60%-597.03%-1,389.76%-609.84%-322.03%-264.42%-362.44%
FCF Margin -4,830.25%-398.02%-151.80%-144.33%-544.98%-667.50%-551.01%-131.86%-164.78%-375.51%-296.68%
Efficiency
Inventory Average 0.70M0.86M0.97M0.95M0.91M
Assets Average 19.66M20.48M13.36M14.36M10.51M9.53M8.76M12.93M
Equity Average 15.49M14.31M7.70M8.14M4.91M2.58M2.32M7.21M
Invested Capital 15.97M15.07M13.63M8.77M6.62M10.78M6.52M3.80M1.36M3.28M11.13M
Asset Utilization Ratio 0.030.100.160.150.220.280.22
Leverage & Solvency
Interest Coverage Ratio -67.46-61.33-69.22
Debt to Equity 0.000.000.010.050.080.110.230.070.01
Debt Ratio 0.000.000.000.030.040.040.040.030.01
Equity Ratio 0.910.690.710.610.540.570.560.370.160.370.65
Times Interest Earned -67.46-61.33-69.22
Valuation
Enterprise Value -14.32M-12.62M-12.66M-10.83M-8.32M-5.74M-3.00M-2.38M-0.11M-0.31M-1.24M-9.53M
Return Ratios
Return on Sales -19.43%-91.65%-2.00%-12.69%-11.87%-6.98%-1.75%-1.98%-5.97%-13.90%-6.10%-3.22%-2.64%-3.62%
Return on Capital Employed -0.35%-0.66%-1.12%-2.91%-5.18%-3.84%-1.41%
Return on Assets -0.32%-0.36%-0.74%-1.06%-1.44%-1.56%-0.79%
Return on Equity -0.45%-0.63%-1.30%-2.28%-5.33%-5.88%-1.43%